Skip to main content
Clinical Trials/CTRI/2021/04/032877
CTRI/2021/04/032877CompletedPhase 3

Comparitive evaluation of effect of Demineralized bone matrix( DMBM) Xenograft with or without concentrated Growth Factor (CGF) in infrabony defect- A Randomised Controlled Clinical Trial.

JNKapoor DAV c Dental College1 site in 1 country24 target enrollmentStarted: April 20, 2021Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
24
Locations
1
Primary Endpoint
Defect depth.

Study Overview

Brief Summary

Study will compare the efficacy of concentrated growth factor in combination with xenograft for the treatment of infrabony defects in the patients having periodontitis. Evaluation will be assessed both clinically and radiographically and will be compared with the  xenograft alone group.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
24.00 Year(s) to 64.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •periodontal probing depth equal to or more than 5mm.
  • •radiographic infrabony bone loss equal to or more than 3 mm.

Exclusion Criteria

  • •Known systemic disease and conditions.
  • •Currently consuming any form of tobacoo.

Outcomes

Primary Outcomes

Defect depth.

Time Frame: Baseline, 3 Months, 6 Months

Amount of defect fill.

Time Frame: Baseline, 3 Months, 6 Months

Percent of defect fil.

Time Frame: Baseline, 3 Months, 6 Months

Amount of defect resolution.

Time Frame: Baseline, 3 Months, 6 Months

Percent of defect resolution.

Time Frame: Baseline, 3 Months, 6 Months

Secondary Outcomes

  • Pocket Depth(Plaque Index)

Investigators

Sponsor
JNKapoor DAV c Dental College
Sponsor Class
Private medical college

Study Sites (1)

Loading locations...

Similar Trials